AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
Related Posts
Procter & Gamble to cut 7,000 jobs as part of broader restructuring
CFO Andre Schulten said more details about the job cuts will be shared on the company’s fiscal fourth-quarter earnings call in July.
Meta, EssilorLuxottica unveil Oakley smart glasses
Meta and EssilorLuxottica debut the Oakley Meta HSTN, which are AI smart glasses pitched toward athletes with a starting price of $399.
LeBron James’ SpringHill to merge with ‘The Kardashians’ producer Fulwell 73
LeBron James’ entertainment company, SpringHill Co., agreed to merge with Fulwell 73, producer of “The Kardashians.”